GlobalRPh renal entry
Abacavir
Ziagen
GlobalRPh source page. Read the exact source scope and cautions.
Label: 0Professional: 1Handbook: 0RX List: 0
Renal Dosing Master
Find the drug. Choose the formulation. Read the renal guidance.
Drug names first. Optional full-text search.
Find a renal dosing reference
Saved and recently opened
Saved drugs
Recently opened
Product / formulation
Abacavir sulfate, lamivudine, and zidovudine (Trizivir), oral tablet
Trizivir / Abacavir sulfate, lamivudine, and zidovudine
Restriction or avoidance · Creatinine clearance (CrCl), mL/min
Local official-label summary. Read the exact source scope and cautions.
New source summary. Independent clinical review pending.
Product / formulation
Abacavir/dolutegravir/lamivudine (Triumeq), fixed-dose oral tablet
Triumeq / Abacavir/dolutegravir/lamivudine
Restriction or avoidance · Creatinine clearance (CrCl), mL/min
Local official-label summary. Read the exact source scope and cautions.
New source summary. Independent clinical review pending.
Product / formulation
Abacavir/lamivudine (KIVEXA, international source)
KIVEXA / NIH ABC/3TC
Local RX List renal extract. Read the exact source scope and cautions.
Product / formulation
Abaloparatide (Tymlos), subcutaneous injection
Tymlos / Abaloparatide
Monitoring guidance · Renal impairment categories as defined by the cited product label
Local official-label summary. Read the exact source scope and cautions.
New source summary. Independent clinical review pending.
Product / formulation
Abemaciclib - VERZENIO tablets
VERZENIO / abemaciclib
Local official-label summary. Read the exact source scope and cautions.
Product / formulation
Abiraterone (ZYTIGA)
Zytiga
Local RX List renal extract. Read the exact source scope and cautions.
Label: 0Professional: 0Handbook: 0RX List: 1
Product / formulation
Abiraterone acetate tablets (Yonsa)
Yonsa
Local official-label summary. Read the exact source scope and cautions.
Product / formulation
Abrocitinib tablets (Cibinqo, adults)
Cibinqo / CIBINQO / abrocitinib
Local official-label summary. Read the exact source scope and cautions.
GlobalRPh renal entry
Acamprosate
CAMPRAL / acamprosate / acamprosate calcium
Local RX List renal extract. Read the exact source scope and cautions.
GlobalRPh renal entry
Acarbose
GlobalRPh source page. Read the exact source scope and cautions.
Label: 0Professional: 0Handbook: 0RX List: 0
Product / formulation
Acetazolamide - oral tablets
acetazolamide tablets / acetazolamide oral
Local RX List renal extract. Read the exact source scope and cautions.
Product / formulation
Acetohydroxamic acid - LITHOSTAT tablets
LITHOSTAT / acetohydroxamic acid
Local RX List renal extract. Read the exact source scope and cautions.
Product / formulation
Aclidinium bromide (Tudorza Pressair), inhaled powder
Tudorza Pressair / Aclidinium bromide
No adjustment within stated limits · Renal impairment categories as defined by the cited product label
Local official-label summary. Read the exact source scope and cautions.
New source summary. Independent clinical review pending.
Product / formulation
Acoramidis - ATTRUBY tablets
ATTRUBY / acoramidis
Local official-label summary. Read the exact source scope and cautions.
GlobalRPh renal entry
Acyclovir
Zovirax
GlobalRPh source page. Read the exact source scope and cautions.
Label: 0Professional: 2Handbook: 0RX List: 0
Product / formulation
Adagrasib tablets (Krazati)
Krazati / KRAZATI
Local official-label summary. Read the exact source scope and cautions.
Label: 1Professional: 0Handbook: 0RX List: 1
GlobalRPh renal entry
Adefovir
HEPSERA
Local RX List renal extract. Read the exact source scope and cautions.
Label: 0Professional: 0Handbook: 0RX List: 1
Product / formulation
Ado-trastuzumab emtansine (KADCYLA)
KADCYLA / eviQ trastuzumab emtansine
Local RX List renal extract. Read the exact source scope and cautions.
Product / formulation
Afatinib - GILOTRIF tablets
GILOTRIF / afatinib
Local official-label summary. Read the exact source scope and cautions.
General renal statement
Aggrenox (aspirin/extended-release dipyridamole)
GlobalRPh general statement. Read the exact source scope and cautions.
Label: 0Professional: 0Handbook: 0RX List: 0
Product / formulation
Albumin human 25% (KEDBUMIN)
KEDBUMIN
Local RX List renal extract. Read the exact source scope and cautions.
Label: 0Professional: 0Handbook: 0RX List: 1
Product / formulation
Alectinib - ALECENSA capsules
ALECENSA / alectinib
Local RX List renal extract. Read the exact source scope and cautions.
Product / formulation
Alendronate (Binosto), effervescent tablet for oral solution
Binosto
Restriction or avoidance · Creatinine clearance (CrCl), mL/min; use the product-specific calculation
Local official-label summary. Read the exact source scope and cautions.
General renal statement
Alendronate sodium tablets
Fosamax
Restriction or avoidance · Creatinine clearance (CrCl), mL/min; use the product-specific calculation
Local official-label summary. Read the exact source scope and cautions.
Product / formulation
Alendronate/cholecalciferol (Fosamax Plus D), fixed-combination oral tablets
Fosamax Plus D
Restriction or avoidance · Creatinine clearance (CrCl), mL/min; use the product-specific calculation
Local official-label summary. Read the exact source scope and cautions.
Product / formulation
Alfuzosin hcl (Uroxatral), oral extended-release tablet
Uroxatral / Alfuzosin hcl
Monitoring guidance · Creatinine clearance (CrCl), mL/min
Local official-label summary. Read the exact source scope and cautions.
New source summary. Independent clinical review pending.
Product / formulation
Alirocumab (Praluent), subcutaneous injection
Praluent / Alirocumab
No adjustment within stated limits · Renal impairment categories as defined by the cited product label
Local official-label summary. Read the exact source scope and cautions.
New source summary. Independent clinical review pending.
Product / formulation
Aliskiren hemifumarate (Tekturna), oral tablet
Tekturna / Aliskiren hemifumarate
Restriction or avoidance · Renal impairment categories as defined by the cited product label
Local official-label summary. Read the exact source scope and cautions.
New source summary. Independent clinical review pending.
Product / formulation
Aliskiren hemifumarate and hydrochlorothiazide (Tekturna HCT), oral tablet
Tekturna HCT / Aliskiren hemifumarate and hydrochlorothiazide
No adjustment within stated limits · Creatinine clearance (CrCl), mL/min
Local official-label summary. Read the exact source scope and cautions.
New source summary. Independent clinical review pending.
GlobalRPh renal entry
Allopurinol
ZYLOPRIM / allopurinol oral / allopurinol
Local official-label summary. Read the exact source scope and cautions.
Product / formulation
Allopurinol - ALOPRIM intravenous infusion
ALOPRIM / allopurinol IV / allopurinol injection
Local official-label summary. Read the exact source scope and cautions.
Product / formulation
Almotriptan (Axert), oral tablets for acute migraine in adults
Axert
Dose or interval change · Clinical renal category or population named in the cited section
Local official-label summary. Read the exact source scope and cautions.
Product / formulation
Alogliptin and pioglitazone (Oseni), oral tablet
Oseni / Alogliptin and pioglitazone
Dose or interval change · Creatinine clearance (CrCl), mL/min
Local official-label summary. Read the exact source scope and cautions.
New source summary. Independent clinical review pending.
Product / formulation
Alogliptin tablets (single agent)
Nesina / NESINA / Alogliptin
Local official-label summary. Read the exact source scope and cautions.
Product / formulation
Alogliptin/metformin tablets (KAZANO)
KAZANO
Local RX List renal extract. Read the exact source scope and cautions.
Label: 0Professional: 0Handbook: 0RX List: 1
Keep the source and the patient context together
1. Choose the exact product
Generic names and brands can lead to different formulations. Select the matching route and release type.
2. Read a whole source
Renal tables retain their indication, units and dialysis assumptions. Do not combine doses and intervals from different protocols.
3. Check the limits
Read source qualifications, monitoring and interactions. A missing dose or absent result does not mean no adjustment.
FROM GLOBALRPH NEPHROLOGY
Continue your clinical reading
Coverage and source limits
See all 26 A-Z review statuses and remaining work | Current evidence additions and verification results
1215 product/formulation records and 1125 selected RX summaries are local. These are selected renal summaries, not complete prescribing monographs. Coverage and independent clinical review remain incomplete.
Review coverage details